AI assistant
Health Catalyst, Inc. — Director's Dealing 2021
Jun 10, 2021
33681_dirs_2021-06-09_b1b89ceb-125b-4290-babf-ed4dd4482493.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Health Catalyst, Inc. (HCAT)
CIK: 0001636422
Period of Report: 2021-06-07
Reporting Person: Burton Daniel D. (N/A)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2021-06-07 | Common Stock | M | 35448.00 | $15.84 | Acquired | 318640.00 | Direct |
| 2021-06-07 | Common Stock | S | 11105.00 | $53.7235 | Disposed | 307535.00 | Direct |
| 2021-06-07 | Common Stock | S | 2992.00 | $54.5352 | Disposed | 304543.00 | Direct |
| 2021-06-07 | Common Stock | S | 38460.00 | $55.7963 | Disposed | 266083.00 | Direct |
| 2021-06-07 | Common Stock | S | 10427.00 | $56.225 | Disposed | 255656.00 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2021-06-07 | Stock Option (Right to Buy) | $15.84 | M | 35448.00 | Disposed | 2029-02-05 | Common Stock (35448.00) | Direct |
Footnotes
F1: The sales reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person on March 4, 2021, in accordance with Rule 10b5-1.
F2: Represents the weighted average sale price of the shares sold ranging from $53.08 to $54.07 per share, inclusive.
F3: Represents the weighted average sale price of the shares sold ranging from $54.10 to $55.04 per share, inclusive.
F4: Represents the weighted average sale price of the shares sold ranging from $55.14 to $56.13 per share, inclusive.
F5: Represents the weighted average sale price of the shares sold ranging from $56.14 to $56.37 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) though (5).
F6: 25% of the 299,748 shares underlying the option vested in an annual installment on February 5, 2020 and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023.